Surgery Partners, Inc. (SGRY)

NASDAQ | Surgical facility services
Free
No email, no account, no signup.
Pulling latest news for Surgery Partners, Inc.…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Sector
Surgical facility services
Market Cap
$1.9B
We're already tracking Surgery Partners, Inc. — here are the latest events we've registered

Recent News

  • On May 5, 2026, Surgery Partners reported first-quarter 2026 revenue of $810.9 million, a 4.5% increase year-over-year, beating analyst expectations. The company reaffirmed its full-year 2026 guidance, projecting revenue between $3.35 billion and $3.45 billion. Management highlighted a strategic focus on musculoskeletal procedures and total joint replacements as key growth drivers.
Want to know how this news affects Surgery Partners, Inc.? Order the analysis.
Order analysis – $4.99

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Surgery Partners, Inc. will be delivered in the same format.
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
Surgery Partners, Inc. (SGRY)
Fresh analysis on demand
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.